Shockwave Medical, Inc.
SWAV
$330.00
$1.010.31%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 202.98M | 186.02M | 180.17M | 161.07M | 144.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 202.98M | 186.02M | 180.17M | 161.07M | 144.03M |
| Cost of Revenue | 25.32M | 24.51M | 24.49M | 21.07M | 17.50M |
| Gross Profit | 177.66M | 161.51M | 155.67M | 140.00M | 126.52M |
| SG&A Expenses | 90.76M | 77.66M | 86.47M | 73.22M | 60.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 158.40M | 141.70M | 147.79M | 121.25M | 101.60M |
| Operating Income | 44.58M | 44.32M | 32.37M | 39.81M | 42.42M |
| Income Before Tax | 55.46M | 45.08M | 33.00M | 40.74M | 44.65M |
| Income Tax Expenses | 11.16M | 10.09M | 4.14M | 1.61M | -96.26M |
| Earnings from Continuing Operations | 44.31M | 34.99M | 28.86M | 39.13M | 140.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.31M | 34.99M | 28.86M | 39.13M | 140.91M |
| EBIT | 44.58M | 44.32M | 32.37M | 39.81M | 42.42M |
| EBITDA | 47.66M | 47.33M | 34.94M | 41.52M | 43.96M |
| EPS Basic | 1.20 | 0.95 | 0.79 | 1.07 | 3.89 |
| Normalized Basic EPS | 0.96 | 0.78 | 0.56 | 0.70 | 0.77 |
| EPS Diluted | 1.15 | 0.92 | 0.76 | 1.03 | 3.70 |
| Normalized Diluted EPS | 0.93 | 0.75 | 0.54 | 0.67 | 0.73 |
| Average Basic Shares Outstanding | 36.93M | 36.80M | 36.66M | 36.43M | 36.18M |
| Average Diluted Shares Outstanding | 38.16M | 38.20M | 38.23M | 37.98M | 37.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
